GO Term | Evidence Code | PMID |
---|---|---|
lung development | ||
ceramide catabolic process | ||
sphingosine biosynthetic process | ||
ceramide biosynthetic process | ||
regulation of programmed necrotic cell death |
GO Term | Evidence Code | PMID |
---|---|---|
transcription corepressor activity | ||
ceramidase activity |
|
|
hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | ||
nuclear receptor binding | ||
fatty acid amide hydrolase activity |
InterPro |
---|
Acid ceramidase, N-terminal |
Acid ceramidase-like |
Choloylglycine hydrolase/NAAA C-terminal |
DO ID | Disease Name | Source |
---|---|---|
DOID:0050464 | Farber lipogranulomatosis | |
DOID:0111527 | spinal muscular atrophy with progressive myoclonic epilepsy | |
DOID:1927 | sphingolipidosis |
Species | Gene ID | OrthoDB | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|---|
427 | HGNC:735 | HUMAN92703 | ||
84431 | 10116_1:0048c6 | RGD:621568 | RATNO11127 | |
173120 | WB:WBGene00010769 | |||
185021 | WB:WBGene00009192 | |||
393549 | ZFIN:ZDB-GENE-040426-1512 | DANRE18275 | ||
450068 | ZFIN:ZDB-GENE-041010-191 | DANRE07067 | ||
464022 | PANTR42053 | |||
482897 | CANLF04758 | |||
510620 | BOVIN21984 | |||
703699 | MACMU43726 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024